Clinical Trials Browser

Phase 4 × Multiple Sclerosis × 90 days × Clear all

NCT04952766 2025-12-23

EREVA

Acquired Immunodeficiency Syndrome, Diabetes Mellitus, Type 2, Hypergammaglobulinemia, Multiple Sclerosis, Neoplasms, Hematologic Neoplasms, Neoplasms, Plasma Cell